To establish the clinical implications of PUS7 and mTOG dysfunctions in MDS, we initially assessed transcriptomic data of bone marrow (BM)-derived CD34+ HSPCs from the largest patient cohort available to date29. The gene discussed is CD34; the disease is myelodysplastic syndrome.